Rajesh Belani

704 total citations
26 papers, 434 citations indexed

About

Rajesh Belani is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Rajesh Belani has authored 26 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Hematology and 6 papers in Genetics. Recurrent topics in Rajesh Belani's work include Neutropenia and Cancer Infections (8 papers), CAR-T cell therapy research (6 papers) and Blood disorders and treatments (6 papers). Rajesh Belani is often cited by papers focused on Neutropenia and Cancer Infections (8 papers), CAR-T cell therapy research (6 papers) and Blood disorders and treatments (6 papers). Rajesh Belani collaborates with scholars based in United States, United Kingdom and Japan. Rajesh Belani's co-authors include Rachel E. Tilley, Jorge J. Nieva, Todd Holscher, Nigel Mackman, Paul Schimmel, Xiang‐Lei Yang, George J. Weiner, Megan Braunlin, Quansheng Zhou and Mili Kapoor and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Rajesh Belani

24 papers receiving 418 citations

Peers

Rajesh Belani
Alicia S. Eustes United States
Maciej Kaźmierczak Poland
Marie Loosveld France
Amleto Fiocchi Italy
Ewa Kurzejamska Sweden
Pierre‐Marie Morice France
Tetsuya Miyake Japan
Marjolein Meinders Netherlands
María N. Barrachina Spain
Michelle E. Maglio United States
Alicia S. Eustes United States
Rajesh Belani
Citations per year, relative to Rajesh Belani Rajesh Belani (= 1×) peers Alicia S. Eustes

Countries citing papers authored by Rajesh Belani

Since Specialization
Citations

This map shows the geographic impact of Rajesh Belani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajesh Belani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajesh Belani more than expected).

Fields of papers citing papers by Rajesh Belani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajesh Belani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajesh Belani. The network helps show where Rajesh Belani may publish in the future.

Co-authorship network of co-authors of Rajesh Belani

This figure shows the co-authorship network connecting the top 25 collaborators of Rajesh Belani. A scholar is included among the top collaborators of Rajesh Belani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajesh Belani. Rajesh Belani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dholaria, Bhagirathbhai, Mehmet H. Kocoglu, Leyla Shune, et al.. (2025). A Phase 1 Study of P-BCMA-ALLO1, a Non-Viral, Allogeneic BCMA Directed CAR-T in Relapsed/Refractory Multiple Myeloma (RRMM): Results from Optimized Lymphodepletion Cohort (Arm C). Transplantation and Cellular Therapy. 31(2). S38–S38.
2.
Jambon, Samy, Meixuan Chen, Rajesh Belani, et al.. (2024). P-CD19CD20-ALLO1: Potent Fully Allogeneic CAR-T Therapy Targeting CD19 and CD20 with Superior Efficacy over Single-Target Products. Blood. 144(Supplement 1). 4805–4805.
3.
Rifkin, Robert M., Jeffrey Crawford, Reshma Mahtani, et al.. (2022). A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices. Supportive Care in Cancer. 30(10). 7913–7922. 9 indexed citations
4.
5.
Skalicky, Anne, et al.. (2021). Development and content validation of the Satisfaction and Experience Questionnaire for Granulocyte Colony-Stimulating Factor (SEQ-G-CSF). Journal of Patient-Reported Outcomes. 5(1). 10–10. 1 indexed citations
6.
Doǧan, Ahmet, David S. Siegel, Alan Fu, et al.. (2020). B-cell maturation antigen expression across hematologic cancers: a systematic literature review. Blood Cancer Journal. 10(6). 73–73. 52 indexed citations
7.
Gawade, Prasad L., Shuling Li, David H. Henry, et al.. (2020). Patterns of granulocyte colony–stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy. Supportive Care in Cancer. 28(9). 4413–4424. 18 indexed citations
8.
9.
Li, Shuling, Jiannong Liu, Tingting Gong, et al.. (2020). Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer. Journal of Geriatric Oncology. 11(8). 1309–1315. 2 indexed citations
10.
Weycker, Derek, Charles Bowers, Rajesh Belani, et al.. (2019). Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study. BMC Cancer. 19(1). 792–792. 14 indexed citations
11.
McNamara, Michelle, et al.. (2019). A Survey of Oncologists’ Perceptions and Opinions Regarding the Use of Granulocyte Colony-Stimulating Factors. Journal of Cancer Education. 35(1). 178–186. 7 indexed citations
12.
Kanaji, Taisuke, My‐Nuong Vo, Sachiko Kanaji, et al.. (2018). Tyrosyl-tRNA synthetase stimulates thrombopoietin-independent hematopoiesis accelerating recovery from thrombocytopenia. Proceedings of the National Academy of Sciences. 115(35). E8228–E8235. 32 indexed citations
13.
Belani, Rajesh, et al.. (2014). ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma. Oncogenesis. 3(7). e111–e111. 11 indexed citations
14.
15.
Zhou, Quansheng, Mili Kapoor, Min Guo, et al.. (2009). Orthogonal use of a human tRNA synthetase active site to achieve multifunctionality. Nature Structural & Molecular Biology. 17(1). 57–61. 63 indexed citations
16.
Tilley, Rachel E., Todd Holscher, Rajesh Belani, Jorge J. Nieva, & Nigel Mackman. (2008). Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thrombosis Research. 122(5). 604–609. 82 indexed citations
17.
Kapoor, Mili, Quansheng Zhou, Francella J. Otero, et al.. (2007). Evidence for Annexin II-S100A10 Complex and Plasmin in Mobilization of Cytokine Activity of Human TrpRS. Journal of Biological Chemistry. 283(4). 2070–2077. 36 indexed citations
18.
Belani, Rajesh & Alan Saven. (2006). Cladribine in Hairy Cell Leukemia. Hematology/Oncology Clinics of North America. 20(5). 1109–1123. 9 indexed citations
19.
Belani, Rajesh & George J. Weiner. (1996). Expression of both B7‐1 and CD28 contributes to the IL‐2 responsiveness of CTLL‐2 cells. Immunology. 87(2). 271–274. 7 indexed citations
20.
Belani, Rajesh & George J. Weiner. (1995). T Cell Activation and Cytokine Production in Anti-CD3 Bispecific Antibody Therapy. Journal of Hematotherapy. 4(5). 395–402. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alicia S. Eustes Breakdown of academic impact, for papers by Maciej Kaźmierczak Breakdown of academic impact, for papers by Marie Loosveld Breakdown of academic impact, for papers by Amleto Fiocchi Breakdown of academic impact, for papers by Ewa Kurzejamska Breakdown of academic impact, for papers by Pierre‐Marie Morice Breakdown of academic impact, for papers by Tetsuya Miyake Breakdown of academic impact, for papers by Marjolein Meinders Breakdown of academic impact, for papers by María N. Barrachina Breakdown of academic impact, for papers by Michelle E. Maglio
Rankless by CCL
2026